Study Site 122 — Cincinnati, Ohio

Study Site 122 is a clinical research site located in Cincinnati, Ohio, United States 45231.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Study Site 122 has participated in 2 clinical trials.

Therapeutic areas: Refractory Chronic Cough, Prurigo Nodularis.

Sponsors: Vyne Therapeutics Inc., Trevi Therapeutics.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 122?

Study Site 122 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 122 conducted?

Study Site 122 has 2 clinical trials on record. Their work covers Refractory Chronic Cough, Prurigo Nodularis.

Is Study Site 122 accredited by Crixeo Health?

Study Site 122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.